Primary cutaneous nodular amyloidosis: Case report and review of the literature

Cutis

Volumn 84, Issue 2, 2009, Pages 87-92

  Schwendiman, Mark N ^a   Beachkofsky, Thomas M ^a,b   Wisco, Oliver J ^b   Owens, Nicole M ^c   Hodson, Darryl S ^d  

^a Des Moines University College of Osteopathic Medicine   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c San Antonio Uniformed Services Health Education Consortium Dermatology Residency   (United States)

^d Skin Surgery Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOSIS; ARTICLE; BIOPSY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; SJOEGREN SYNDROME; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMYLOIDOSIS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SJOGREN'S SYNDROME; SKIN DISEASES;

EID: 77953944975     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Woollons A, Black MM. Nodular localized primary cutaneous amyloidosis: a long-term follow-up study. Br J Dermatol. 2001;145:105-109.
2. Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis review and long-term follow-up of 16 cases. Arch Dermatol. 2003;139:1157-1159.
3. Chotzen VA, Gandour-Edwards R, Zang MK, et al. Longterm AL primary amyloidosis. a case report. Dermatol Online J. 1995;1:6.
4. James WD, Berger TG, Elston DM. Errors in metabolism. In: James WD, Berger TG, Elston DM. Andrews' Diseases of the Skin. 10th ed. Philadelphia, PA: WB Saunders Co; 2006:519-546.
5. Silverstein SR. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Dermatol Online J. 2005; 11:5.
6. Touart DM, Sau P. Cutaneous deposition diseases. part I. J Am Acad Dermatol. 1998;39(3, pt 1):149-171.
7. Steciuk A, Dompmartin A, Troussard X, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol. 2002;41:127-132.
8. Wolff K, Johnson RA, Suurmond D. Skin signs of immune, autoimmune, and rheumatic diseases. In: Wolff K, Johnson RA, Suurmond D, eds. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. 5th ed. New York, NY: McGraw-Hill Medical Publishing; 2005:356-431.
9. Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol. 1988;18(1, pt 1):1-16.
10. Kyle RA. Amyloidosis. Circulation. 1995;91:1269-1271.
11. Rubinow A, Cohen AS. Skin involvement in generalized amyloidosis: a study of clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis. Ann Intern Med. 1978;88:781-785.
12. Grunewald K, Sepp N, Weyrer K, et al. Gene rearrangement studies in the diagnosis of primary systemic and nodular primary localized cutaneous amyloidosis. J Invest Dermatol. 1991;97:693-696.
13. Black MM, Upjohn E, Albert S. Amyloidosis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Vol 1. 2nd ed. Spain: Mosby Elsevier; 2008:623-632.
14. Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol. 1992;26:885-902.
15. Pedace FJ, Perry HO. Granuloma faciale: a clinical and histopathologic review. Arch Dermatol. 1966;94:387-395.
16. Black MM. Lipoid proteinosis; metabolic and nutritional disorders. In: Champion RH, Burton JL, Burns T, et al, eds. Rook/Wilkinson/Ebling: Textbook of Dermatology. 6th ed. Oxford, England: Blackwell Science; 1998: 2577-2677.
17. Muda AO, Paradisi M, Angelo C, et al. Lipoid proteinosis: clinical, histologic, and ultrastructural investigations. Cutis. 1995;56:220-224.
18. Burrows NP, Lovell CR. Disorders of connective tissue. In: Burns T, Breathnach S, Cox N, et al, eds. Rook's Textbook of Dermatology. Vol 3. 7th ed. Oxford, England: Blackwell Scientific; 2004:chap 46.1.
19. Hashimoto K, Black M. Colloid milium: a final degeneration product of actinic elastoid. J Cutan Pathol. 1985;12:147-156.
20. Hashimoto K, Miller F, Bereston ES. Colloid milium: histochemical and electron microscopic studies. Arch Dermatol. 1972;105:684-694.
21. Kalajian AH, Waldman M, Knable AL. Nodular primary localized cutaneous amyloidosis after trauma: a case report and discussion of the rate of progression to systemic amyloidosis. J Am Acad Dermatol. 2007;57(suppl 2): S26-S29.
22. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45-59.
23. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med. 1990;323: 508-513.
24. Hazenberg BP, van Rijswijk MH, Piers DA, et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med. 2006;119(4):355.e15-e24.
25. Meijer JM, Schonland SO, Palladini G, et al. Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58:1992-1999.
26. Praprotnik S, Tomsic M, Perkovic T, et al. Is Sjögren's syndrome involved in the formation of localized nodular amyloidosis? Clin Exp Rheumatol. 2001;19:735-737.
27. Summers EM, Kendrick CG. Primary localized cutaneous nodular amyloidosis and CREST syndrome: a case report and review of the literature. Cutis. 2008;82: 55-59.
28. Azón-Masoliver A. Widespread primary localized cutaneous amyloidosis (macular form) associated with systemic sclerosis. Br J Dermatol. 1995;132:163-165.